1. MarketsandMarkets Presents Non-invasive Prenatal Testing (NIPT) Market size and trend during the Forecast Period Next Five years https://www.marketsandmarkets.com/Market-Reports/non-invasive-prenatal-testing-market-145607690.html

2. The report "Non-Invasive Prenatal Testing (NIPT) Market by Instruments (Ultrasound, NGS, PCR, Microarray), Consumables, Method (FCMB, cf- DNA), Application (Trisomy, Microdeletion, Genetics, Rh factor) & End User (Hospital, Diagnostic Labs) - Global Forecast to 2021", analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia, and the Rest of the World (RoW)Non-Invasive Prenatal Testing (NIPT) Market Browse 110 market data tables and 48 figures spread through 150 pages and in- depth TOC on "Non-Invasive Prenatal Testing (NIPT) Market by Instruments (Ultrasound, NGS, PCR, Microarray), Consumables, Method (FCMB, cf- DNA), Application (Trisomy, Microdeletion, Genetics, Rh factor) & End User (Hospital, Diagnostic Labs) - Global Forecast to 2021. https://www.marketsandmarkets.com/Market-Reports/non-invasive-prenatal-testing-market-145607690.html

3. Early buyers will receive 10% customization on this report. https://www.marketsandmarkets.com/Market-Reports/non-invasive-prenatal-testing-market-145607690.html

4. The non-invasive prenatal testing market is witnessing significant growth across the globe owing to factors such as high risk of chromosomal abnormalities with increasing maternal age, growing preference for non- invasive techniques over invasive methods, launch of new and advanced products, improving reimbursement scenario for NIPT, and programs focusing on increasing the awareness of NIPT. The increasing use of NIPT in detection of Trisomy (Down syndrome, Edwards’s syndrome, and Patau syndrome), Microdeletion syndrome, and other applications (Monogenic disorders, Klinefelter syndrome, gender detection, and rhesus (Rh) blood type) also play a vital role in the development of this market. Key players in the market focus on partnerships, collaborations, and agreements; product launches, expansions; and acquisitions to strengthen their positions in the global market. https://www.marketsandmarkets.com/Market-Reports/non-invasive-prenatal-testing-market-145607690.html

5. The NIPT market is segmented based on product, method, application, end user, and region. On the basis of product, the market is segmented into consumables and instruments. The consumables segment offer lucrative growth opportunities and represent a new revenue pocket for the market owing to the repeated requirements of consumables in NIPT. The consumables segment is further divided into assay kits & reagents and disposables. The instruments segment is classified into ultrasound devices, NGS systems, PCR instruments, microarrays, and other instruments. On the basis of method, the NIPT market is segmented into ultrasound detection, biochemical screening tests, fetal cells in maternal blood tests, and cell-free DNA in maternal plasma tests. In 2016, the ultrasound detection segment accounted for the largest share of the NIPT market. However, the cell-free DNA in maternal plasma tests segment is expected to grow at the highest CAGR during the forecast period. The increasing demand for cf-DNA based techniques in NIPT testing and rising government initiatives to provide prenatal services are expected to contribute to the growth of this market in the coming years. https://www.marketsandmarkets.com/Market-Reports/non-invasive-prenatal-testing-market-145607690.html

6. On the basis of application, the NIPT market is segmented into Trisomy, microdeletion syndrome, and other applications. Trisomy forms the largest application segment and is slated to grow at the highest CAGR during the forecast period. This is mainly attributed to the increasing maternal age and rising incidence of chromosomal abnormalities. On the basis of end user, the NIPT market is segmented into diagnostic laboratories and hospitals. In 2016, the diagnostic laboratories segment accounted for the largest share of the market. Growth in this end-user segment can be attributed to the high incidence of chromosomal abnormalities. https://www.marketsandmarkets.com/Market-Reports/non-invasive-prenatal-testing-market-145607690.html

8. Currently, North America dominates the market, followed by Europe. However, the market in Asia is expected to witness the highest growth due to the increasing healthcare infrastructure. In addition, increasing awareness programs, rising disposable income, and increasing interest of players to expand in these emerging economies will propel the growth of the market. https://www.marketsandmarkets.com/Market-Reports/non-invasive-prenatal-testing-market-145607690.html

9. Contact Us Contact: Mr. Shelly Singh Markets and Markets UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar Pune, Maharashtra 411013, India 1-888-600-6441 Email: sales@marketsandmarkets.comsales@marketsandmarkets.com http://www.linkedin.com/company/marketsandmarkets https://www.marketsandmarkets.com/Market-Reports/non-invasive-prenatal-testing-market-145607690.html

10. About MarketsandMarkets MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. They cover thirteen industry verticals, including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT. We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. https://www.marketsandmarkets.com/Market-Reports/non-invasive-prenatal-testing-market-145607690.html